Panacea Biotec Limited (NSE:PANACEABIO)
India · Delayed Price · Currency is INR | Market Cap | 24.36B -6.7% |
| Revenue (ttm) | 6.73B +10.3% |
| Net Income | -71.20M |
| EPS | -1.17 |
| Shares Out | 61.25M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 89,617 |
| Open | 387.90 |
| Previous Close | 388.65 |
| Day's Range | 383.45 - 399.95 |
| 52-Week Range | 292.40 - 647.00 |
| Beta | 0.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 13, 2026 |
About Panacea Biotec
Panacea Biotec Limited, a biotechnology company, engages in the research, development, manufacture, and marketing of vaccines, pharmaceutical formulations, nutraceuticals, and food and nutrition products in India and internationally. It operates through Vaccines and Pharmaceutical formulations & Nutrition segments. The company’s product portfolio includes prescription products in various therapeutic areas, such as oncology, diabetes, gastro-intestinal care, nephrology, orthopedics, pain management, and fever; cold and cough; and betacoronavirus... [Read more]
Financial Performance
In fiscal year 2026, Panacea Biotec's revenue was 6.40 billion, an increase of 14.43% compared to the previous year's 5.59 billion. Losses were -53.70 million, -35.84% less than in 2025.
Financial StatementsNews
Panacea Biotec reports no change in dematerialised shares for June 2026
Panacea Biotec Limited has reported that there were no shares dematerialised during June 2026, according to a regulatory filing with the National Stock Exchange of India (NSE). The total number…
Pharma sector stocks today, July 6: Panacea Biotec surges 2.47%, Ajanta Pharma gains 1.48%, Glenmark Pharma up 1.29%
Indian pharmaceutical stocks showed mixed movements in early trading on July 6, 2026. The broader market indices recorded modest gains, with the Nifty 50 up 0.42% at 24,372.30 and the…
Pharma sector stocks today, July 1: Panacea Biotec surges 4.30%, Biocon jumps 1.78%, Wockhardt up 1.66%
The Indian pharmaceutical sector displayed mixed performance in early trading on July 1, 2026. The S&P BSE Healthcare index stood at 49,349.56, up 0.09%. Broader market indices also opened positively,...
Pharma sector stocks today, June 25: Panacea Biotec rises 3.26%, Dr. Reddy's Lab up 2.01%, Orchid Pharma falls 1.70%
Pharma stocks traded with a mixed-to-positive bias on June 25, 2026, during the early morning session, with several mid-cap names posting healthy gains while a few counters slipped into the…
Pharma sector stocks today, June 24: Orchid Pharma up 3.72%, Dr. Reddys Lab gains 2.38%, Panacea Biotech falls 1.18%
Pharma stocks traded broadly in positive territory on June 24, 2026, during the early morning session, with most stocks posting modest gains. The broader market was largely flat, with the…
Pharma sector stocks rises today, June 18: Wockhardt up 2.86%, Natco Pharma gains 2.38%, Panacea Biotech rises 2.01%
Pharma stocks traded broadly in positive territory on June 18, 2026, during the early morning session, with most stocks posting gains. The broader market was largely flat, with the Nifty…
Pharma sector stocks today, June 17: Aurobindo Pharma gains 2.26%, Panacea Biotech falls 1.80%, Cipla down 0.32%
Pharma stocks traded mixed on June 17, 2026, during the early morning session, with gains and losses spread across the sector. The broader market was positive, with the Nifty 50…
Pharma sector stocks today, June 16: Sudeep Pharma up 3.09%, Panacea Biotech gains 0.89%, Indoco Remedies falls 1.13%
Pharma stocks traded mixed on June 16, 2026, during the early morning session, with modest gains and losses spread across the sector. The broader market was positive, with the Nifty…
Pharma sector stocks rise today, June 12: Panacea Biotech gains 2.50%, Wockhardt rises 2.24%, Natco Pharma up 1.36%
Pharma stocks traded broadly in positive territory on June 12, 2026, during the early morning session, with most stocks posting gains. The broader market was also strong, with the Nifty…
Pharma sector stocks today, June 10: Panacea Biotech falls 8.09%, Wockhardt declines 1.47%, Alembic Pharma up 1.02%
Pharma stocks traded mixed on June 10, 2026, during the early morning session, with gains and losses spread across the sector. The broader market was positive, with the Nifty 50…
Pharma sector stocks today, June 9: Panacea Biotech surges 9.11%, Divis Laboratories up 3.46%, Ajanta Pharma gains 1.86%
Pharma stocks traded largely in positive territory on June 9, 2026, during the morning session, with most stocks posting gains. The broader market was stable, with the Nifty 50 up…
Panacea Biotec shares price jumps over 7% after launch of global dengue vaccine project DENSTAR
Panacea Biotec shares jumped more than 7% in early trade on Tuesday after the company announced the launch of the DENSTAR project, a major international initiative aimed at advancing the…
Panacea Biotec launches DENSTAR project to advance dengue vaccine in Africa
Panacea Biotec has announced the launch of the DENSTAR project, aimed at advancing the licensure of its tetravalent live-attenuated dengue vaccine, DengiAll®, in sub-Saharan Africa and facilitating it...
Panacea Biotec reports dematerialisation of 6.11 crore shares in May 2026
Panacea Biotec has reported the dematerialisation of a total of 6,11,05,526 shares as of 31 May 2026. This includes 5,39,04,650 shares under the National Securities Depository Limited (NSDL) and 72,00...
Pharma sector stocks today, June 5: Panacea Biotech up 6.14%, Wockhardt falls 6.49%, Natco Pharma down 1.79%
Pharma stocks traded mixed on June 5, 2026, during the late morning session, with a majority of stocks posting gains while a handful remained under selling pressure. The broader market…
Pharma sector stocks today, June 4: Panacea Biotech up 7.24%, Wockhardt gains 3.09%, Natco Pharma falls 1.63%
Pharma stocks traded mixed on June 4, 2026, during the early morning session, with several stocks posting gains while others remained under mild selling pressure. The broader market was relatively…
Panacea Biotec appoints Krishan Kumar Jalan as independent director for PBPL
Panacea Biotec has announced the appointment of Mr. Krishan Kumar Jalan as an additional non-executive independent director of its wholly owned subsidiary, Panacea Biotec Pharma Limited (PBPL). The ap...
Pharma sector stocks today, May 27: Panacea Biotech rises 2.83%, Wockhardt up 2.71%, Aurobindo Pharma down 0.17%
Pharmaceutical stocks traded mixed during the morning session on May 27, 2026. While some stocks posted decent gains, a few names saw mild selling pressure. The BSE Healthcare index rose…
Pharma sector stocks today, May 21: Panacea Biotech up 1.57%, Aurobindo Pharma jumps 1.37%, Torrent Pharma gains 1.48%
Pharmaceutical stocks traded mixed on May 21, 2026, during the morning session. While some stocks posted decent gains, several others saw mild selling pressure. The BSE Healthcare index rose 0.58%…
Panacea Biotec reports no shares dematerialised in April 2026
Panacea Biotec has announced that no shares were dematerialised during April 2026. The company confirmed this in its regulatory filing, citing compliance with Regulation 74(5) of the SEBI (Depositorie...
Pharma sector stocks today, May 7: Wockhardt falls 4%, Panacea Biotec jumps 2.16%, Biocon up 1%
Pharma sector performance remained largely stable in early trading on May 7, 2026. The NIFTY PHARMA Index stood at 24,108.9, showing no change (down 0.0%). The broader S&P BSE HEALTHCARE…
Pharma sector stocks today, April 20: Panacea Biotech falls 2.23%, Alembic Pharma down 2.20%, Strides Pharma gains 1.43%
Pharmaceutical sector stocks traded mixed in early trade on Monday, April 20, 2026, with most counters under mild pressure. The S&P BSE Healthcare Index declined 0.33% to 43,343.25, while the…
Panacea Biotec secures Rs 20.79 crore contract for Td vaccine supply
Panacea Biotec has announced the receipt of a Letter of Award from the Central Medical Services Society (CMSS), under the Ministry of Health and Family Welfare, Government of India. The…
Pharma sector stocks surge today, March 18: Alembic jumps 2.87%, Panacea Biotec up 2.84%, Gland Pharma rises 2.69%
The pharmaceutical sector stocks in India showed positive movement on March 18, 2026, during early trading hours, with many scrips recording gains on both BSE and NSE. The S&P BSE…
India Close To Dengue Vaccine: All About The Phase 3 Trials And More
DengiAll, which is Panacea Biotec's tetravalent live-attenuated vaccine, uses weakened strains of all four DENV serotypes. As a single-dose shot, it simplifies administration compared to other multi-d...